Lifeward Ltd, formerly known as ReWalk Robotics Ltd, is a medical device company. The Company is engaged in designing, developing, and commercializing exoskeletons that allow individuals with mobility impairments or other medical conditions the ability to stand and walk again. The Company offers an exoskeleton that uses its tilt-sensor technology and an onboard computer and motion sensors to drive motorized legs that power movement. Lifeward designs are intended for people with paraplegia, a spinal cord injury resulting in complete or incomplete paralysis of the legs, having the use of their upper bodies and arms. The Company offers multiple products: ReWalk Personal, ReStore Exo-Suit, MYOLYN FES Cycling, and AlterG Anti-Gravity Systems. ReWalk Personal is designed for everyday use by paraplegic individuals at home and in their communities and is custom-fitted for each user. Lifeward Rehabilitation products are for use by paraplegia patients in the clinical rehabilitation environment.
High Growth
The company's revenue has grown steadily over the past 3 years, averaging 59.04% year-on-year.
Growing
The company is in a growing phase, with the latest annual income totaling USD 22.03M.
Overvalued
The company’s latest PE is -0.04, at a high 3-year percentile range.
Institutional Selling
The latest institutional holdings are 58.22K shares, decreasing 68.75% quarter-over-quarter.
Held by James Simons
Star Investor James Simons holds 0.00 shares of this stock.